CORRECTION article

Front. Oncol., 01 February 2024

Sec. Neuro-Oncology and Neurosurgical Oncology

Volume 14 - 2024 | https://doi.org/10.3389/fonc.2024.1372295

Corrigendum: Bevacizumab-Irinotecan combination therapy in recurrent low-grade glioma, previously treated with chemo-radiotherapy: a case report

  • 1. Health Sciences Department, University of Florence, Florence, Italy

  • 2. Neuro-Oncology Unit, Meyer Children’s Hospital IRCCS, Florence, Italy

  • 3. Radiology Unit, Meyer Children’s Hospital IRCCS, Florence, Italy

  • 4. Pathology Unit, Meyer Children’s Hospital IRCCS, Florence, Italy

  • 5. Radiotherapy Unit, University of Florence, Florence, Italy

  • 6. Neurosurgery Unit, Meyer Children’s Hospital IRCCS, Florence, Italy

In the published article, there was an error in affiliations 2,3,4,6. Instead of “Meyer Children’s Hospital Scientific Institute for Research, Hospitalization and Healthcare (IRCCS),” it should be “Meyer Children’s Hospital IRCCS.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

low-grade gliomas, bevacizumab, irinotecan, pilocytic astrocytoma, case report

Citation

Castelli B, Fonte C, Guidi M, Tellini M, Di Nicola M, Iacono A, Buccoliero AM, Greto D, Genitori L and Sardi I (2024) Corrigendum: Bevacizumab-Irinotecan combination therapy in recurrent low-grade glioma, previously treated with chemo-radiotherapy: a case report. Front. Oncol. 14:1372295. doi: 10.3389/fonc.2024.1372295

Received

17 January 2024

Accepted

19 January 2024

Published

01 February 2024

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

14 - 2024

Updates

Copyright

*Correspondence: Barbara Castelli,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics